- GLP-1 RAs are very potential for stroke and more studies are needed to elucidate the mechanisms underlying neuroprotection
these are, however, transdermal patches, capsules, powders, effervescent tablets, sold as weight-loss and blood-sugar aids, priced between 150 and 3,500
Semaglutide Weekly Injection Active Ingredient in Ozempic and Wegovy 15% Body Weight Reduction GLP-1 Receptor Agonist FDA Approved for Type 2 Diabetes (2017) and Weight Loss (2021) Most Common Side Effects: Nausea, Diarrhea, Vomiting, Constipation, Indigestion, and Abdominal Pain Tirzepatide Weekly Injection Active Ingredient in Mounjaro 20% Body Weight reduction Dual GLP-1 and GIP Receptor Agonist FDA Approved for Type 2 Diabetes (2022) and on Fast-track for Weight Loss Approval in 2023 Most Common Side Effects: Nausea, Diarrhea, Vomiting, Constipation, Indigestion, and Abdominal Pain These injections are GLP-1 medications that have been FDA-approved for Type 2 diabetes because of their ability to lower blood sugar and raise insulin levels
Use amber or opaque vials to block UV light exposure, which catalyzes oxidation and can degrade potency by 2030% within 72 hours under fluorescent or sunlight